We are live on
!
Find out more
Alphabet Inc Portfolio holdings
AUM
$99.1B
Turnover
13.79%
1-Year Est. Return
124.46%
This Fund
S&P 500
This Quarter
Est. Return
-14.79%
1 Year Est. Return
+124.46%
3 Year Est. Return
+326.82%
5 Year Est. Return
+231.24%
10 Year Est. Return
+1,201.66%
AUM
$4.14B
AUM Growth
-$73.7M
(-1.7%)
Cap. Flow
+$1.39B
Cap. Flow
% of AUM
33.49%
Top 10 Holdings %
Top 10 Hldgs %
76.41%
Holding
58
New
15
Increased
–
Reduced
10
Closed
–
Avg Time Held
1
year
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EQRX
EQRx, Inc. Common Stock
EQRX
|
+$449M |
| 2 |
Toast
TOST
|
+$439M |
| 3 |
IonQ
IONQ
|
+$365M |
| 4 |
Planet Labs
PL
|
+$303M |
| 5 |
Freshworks
FRSH
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UiPath
PATH
|
+$173M |
| 2 |
Robinhood
HOOD
|
+$85.2M |
| 3 |
Duolingo
DUOL
|
+$78.2M |
| 4 |
Arcus Biosciences
RCUS
|
+$59.6M |
| 5 |
DexCom
DXCM
|
+$58.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 47.22% |
| 2 | Technology | 41.43% |
| 3 | Industrials | 6.55% |
| 4 | Consumer Staples | 2.6% |
| 5 | Financials | 2.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
UiPath
PATH
$6.81B
| $607M | 14.65% |
14,068,674
-3,512,754
| -20% | -$173M |
2021 Q2
2 quarters
|
|
2
DELISTED
Verve Therapeutics
VERV
| $405M | 9.77% |
10,974,011
| – | – |
2021 Q2
2 quarters
|
|
|
3
DexCom
DXCM
$31.5B
| $378M | 9.13% |
2,816,044
-406,680
| -13% | -$58.4M |
2018 Q4
12 quarters
|
|
|
4
IonQ
IONQ
$12.7B
| $366M | 8.83% |
+21,907,038
| New | +$365M |
2021 Q4
0 quarters
|
|
|
5
Toast
TOST
$17.3B
| $330M | 7.96% |
+9,496,884
| New | +$439M |
2021 Q4
0 quarters
|
|
|
EQRX
6
DELISTED
EQRx, Inc. Common Stock
EQRX
| $324M | 7.83% |
+47,552,687
| New | +$449M |
2021 Q4
0 quarters
|
|
7
Lyft
LYFT
$6.24B
| $262M | 6.33% |
6,138,154
| – | – |
2019 Q1
11 quarters
|
|
|
8
Planet Labs
PL
$5.14B
| $196M | 4.74% |
+31,942,641
| New | +$303M |
2021 Q4
0 quarters
|
|
9
Oscar Health
OSCR
$10.6B
| $189M | 4.56% |
24,042,864
| – | – |
2021 Q1
3 quarters
|
|
10
DELISTED
Benson Hill, Inc.
BHIL
| $108M | 2.6% |
421,493
| – | – |
2021 Q3
1 quarter
|
|
|
11
Freshworks
FRSH
$3.57B
| $106M | 2.56% |
+4,035,595
| New | +$146M |
2021 Q4
0 quarters
|
|
|
12
Arcus Biosciences
RCUS
$2.87B
| $104M | 2.51% |
2,563,441
-1,537,034
| -37% | -$59.6M |
2018 Q1
15 quarters
|
|
|
13
Robinhood
HOOD
$90.9B
| $87.5M | 2.11% |
4,928,535
-2,768,800
| -36% | -$85.2M |
2021 Q3
1 quarter
|
|
14
DELISTED
Desktop Metal, Inc.
DM
| $54.7M | 1.32% |
1,104,873
| – | – |
2020 Q4
4 quarters
|
|
15
Relay Therapeutics
RLAY
$3.74B
| $48M | 1.16% |
1,564,173
-77,324
| -5% | -$2.44M |
2020 Q3
5 quarters
|
|
16
Lyell Immunopharma
LYEL
$196M
| $45.4M | 1.1% |
293,256
| – | – |
2021 Q2
2 quarters
|
|
17
DELISTED
23andMe Holding Co
ME
| $44.9M | 1.08% |
+336,839
| New | +$62.2M |
2021 Q4
0 quarters
|
|
18
Sana Biotechnology
SANA
$698M
| $43.5M | 1.05% |
2,812,500
| – | – |
2021 Q1
3 quarters
|
|
19
Invivyd
IVVD
$179M
| $41.2M | 1% |
5,680,785
| – | – |
2021 Q3
1 quarter
|
|
|
SNCE
20
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $40.4M | 0.98% |
+162,054
| New | +$36M |
2021 Q4
0 quarters
|
|
21
Monte Rosa Therapeutics
GLUE
$839M
| $29.9M | 0.72% |
1,464,015
| – | – |
2021 Q2
2 quarters
|
|
22
Beam Therapeutics
BEAM
$2.44B
| $25.6M | 0.62% |
321,604
| – | – |
2020 Q1
7 quarters
|
|
23
DELISTED
RAPT Therapeutics
RAPT
| $23.1M | 0.56% |
78,470
-10,311
| -12% | -$2.76M |
2019 Q4
8 quarters
|
|
24
Illumina
ILMN
$41B
| $20.3M | 0.49% |
54,967
| – | – |
2021 Q3
1 quarter
|
|
|
ENJY
25
DELISTED
Enjoy Technology, Inc. Common Stock
ENJY
| $20.1M | 0.48% |
+4,345,340
| New | +$32.3M |
2021 Q4
0 quarters
|
|
Similar funds
Alphabet Inc's Q4 2021 Portfolio in Review
As of Q4 2021, Alphabet Inc held 58 positions worth $4.14B, down 1.7% from $4.22B the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Alphabet Inc deployed $1.39B of net new capital in Q4 2021, opening 15 new positions. Its largest new stake was EQRx, Inc. Common Stock: 47,552,687 shares worth $324M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 55% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was UiPath, an estimated $173M trimmed.
- Alphabet Inc's largest Q4 2021 buy was EQRx, Inc. Common Stock: 47,552,687 shares worth $324M.
- Alphabet Inc's biggest Q4 2021 reduction was UiPath, cutting an estimated $173M.
- Alphabet Inc's ten largest holdings make up 76% of its $4.14B portfolio in Q4 2021.
- Alphabet Inc opened 15 new positions and closed 0 in Q4 2021.
- Alphabet Inc's portfolio value fell 1.7% quarter-over-quarter to $4.14B.
Based on Alphabet Inc's 13F filing for Q4 2021, filed 15 Nov 2022.